French pharmaceutical firm Advanced Accelerator Applications (AAA) has raised €4.8m from existing and new investors, including incoming venture capital investor Seventure Partners.
Versant has launched the T-cell therapy developer in partnership with the University of Basel
TCS managing director Dave McCabe will stay on with the combined company
Add-on shortly follows the acquisition of Italian university Accademia Italiana Arte Moda e Design
Round also saw participation from existing investors Karma Ventures, Inovo Venture Partners and Dreamit Ventures